Facebook icon Twitter icon Forward icon

Sanofi’s Insulin Toujeo® available for treatment of adults with diabetes in UK

Sanofi has announced that Toujeo® (insulin glargine [rDNA origin] 300 units/mL), a long-acting, once-daily basal insulin treatment is available for clinicians to prescribe in the UK.

The drug has demonstrated similar glycaemic control with a lower incidence of confirmed hypoglycaemia when compared to Lantus® in the treatment of adults with type 2 diabetes. To read more, click here.

Diabetes UK announce new Chief Executive

A cancer charity boss will be the new Chief Executive of Diabetes UK.

Chris Askew will take the reigns at the charity on September 14, replacing Barbara Young. To read more, click here.

Deadline for National Diabetes Audit

The deadline for submitting data for the annual National Diabetes Audit (NDA) is Friday 4 September 2015.

The NDA is the largest annual clinical review in the world and integrates data from both primary and secondary care sources. To read more, click here.

Diabetes prescriptions make up 10% of drugs bill

Diabetes prescriptions account for 10 per cent of the NHS drugs bill in primary care, according to new figures.

A total of £868.6 million was spent managing diabetes, a report by the Health and Social Care Information Centre (HSCIC) has found. To read more, click here.

Ninjabetic – It's not just a questionnaire...

Recently a friend and I were discussing her PhD subject. We talked about the use of questionnaires for research purposes and we agreed that questionnaires, which could provoke negative thoughts and feelings from people with diabetes need to be followed up with the offer of a debrief and support. To read more, click here.

Deadline looms for diabetes hero awards

People have less than a week left to nominate their “diabetes hero” for a national awards programme. The deadline to put names forward for the Outstanding Educator in Diabetes and the Diabetes People’s Award in the Quality in Care (QiC) diabetes awards is August 19. To read more, click here.